Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
2023 · External reference
Epidemiology and natural history of patients with NAFLD
10.2174/13816128113199990336 · 2013 · External reference
Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort
10.1002/hep.28677 · 2016 · External reference
Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations
10.1007/s10620-016-4143-0 · 2016 · External reference
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
10.1038/nrgastro.2017.109 · 2018 · External reference
editors. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
1980 · External reference
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases
10.1002/hep.29367 · 2018 · External reference
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
10.1053/j.gastro.2012.04.001 · 2012 · External reference
Nonalcoholic fatty liver disease: a systematic review
10.1001/jama.2015.5370 · 2015 · External reference
Natural history of simple steatosis or nonalcoholic fatty liver
10.1016/j.jceh.2019.09.005 · 2020 · External reference
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
10.1016/j.atherosclerosis.2013.10.030 · 2014 · External reference
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
10.1002/hep.28431 · 2016 · External reference
The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background
2016 · External reference
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
2023 · External reference
A comprehensive definition for metabolic syndrome
10.1242/dmm.001180 · 2009 · External reference
The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis
10.1016/j.cld.2015.10.002 · 2016 · External reference
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management
10.1016/j.gtc.2016.07.003 · 2016 · External reference
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis
10.1016/j.cgh.2017.09.041 · 2018 · External reference
Prevalence and trends in obesity among US adults, 1999–2008
10.1001/jama.2009.2014 · 2010 · External reference
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
10.1053/j.gastro.2010.09.038 · 2011 · External reference
Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin
10.1007/s11892-015-0674-6 · 2015 · External reference
The prevalence and etiology of elevated aminotransferase levels in the United States
10.1111/j.1572-0241.2003.07486.x · 2003 · External reference
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease
10.1002/hep.20554 · 2005 · External reference
Epidemiology and natural history of NAFLD and NASH
10.1016/j.cld.2007.02.009 · 2007 · External reference
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
10.1111/j.1365-2036.2011.04724.x · 2011 · External reference
Epidemiology and natural history of non-alcoholic steatohepatitis
10.1016/j.cld.2009.07.005 · 2009 · External reference
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
10.1002/hep.20466 · 2004 · External reference
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
10.1210/jc.2015-1966 · 2015 · External reference
Hepatitis B and C in African Americans: current status and continued challenges
10.1016/j.cgh.2013.06.006 · 2014 · External reference
Description and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model
10.1186/1471-2458-14-1033 · 2014 · External reference
Metabolic Syndrome Severity Predicts Mortality in Nonalcoholic Fatty Liver Disease
10.1016/j.gastha.2022.02.002 · 2022 · External reference
Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the Multi-Ethnic Study of Atherosclerosis
10.1089/met.2010.0050 · 2011 · External reference
An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score
10.1016/j.metabol.2013.10.006 · 2014 · External reference
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
10.2147/dmso.s101624 · 2017 · External reference
Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study
10.1186/s13098-018-0344-3 · 2018 · External reference
Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study
10.1007/s00125-017-4267-6 · 2017 · External reference
Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes
10.1186/s12933-017-0647-y · 2018 · External reference
Unresolved reference
External reference
The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population
10.1097/mcg.0000000000000666 · 2017 · External reference
Unresolved reference
External reference
10.1007/978-3-319-19425-7
10.1007/978-3-319-19425-7 · 2015 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007 · External reference
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?
10.1002/hep.32499 · 2022 · External reference
NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III
10.3389/fmed.2021.693507 · 2021 · External reference
Sex-specific differences in the association between race/ethnicity and NAFLD among US population
2021 · External reference
Racial differences in prevalence and severity of non-alcoholic fatty liver disease
10.4254/wjh.v13.i7.763 · 2021 · External reference
Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity
10.1007/s13679-019-00349-x · 2019 · External reference
Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors
10.1016/j.numecd.2010.05.006 · 2012 · External reference
African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population
10.1016/j.aohep.2022.100728 · 2022 · External reference
The triglyceride paradox in people of African descent
10.1089/met.2011.0108 · 2012 · External reference
Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes
10.1038/ijo.2017.309 · 2018 · External reference
Nonalcoholic fatty liver disease: lipids and insulin resistance
10.1016/j.cld.2015.10.007 · 2016 · External reference
Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects
10.2337/diabetes.50.7.1612 · 2001 · External reference
Nonalcoholic Fatty Liver Disease
10.1016/j.cld.2016.02.001 · 2016 · External reference
Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
10.1016/j.jhep.2014.01.009 · 2014 · External reference
Non-alcoholic fatty liver disease in diabetics—prevalence and predictive factors in a multiracial hospital clinic population in Malaysia
10.1111/jgh.12204 · 2013 · External reference
Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease
10.1080/13696998.2022.2026702 · 2022 · External reference
Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease
10.1001/jamanetworkopen.2022.35003 · 2022 · External reference
Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity
10.1053/j.gastro.2021.03.021 · 2021 · External reference
